![](/img/cover-not-exists.png)
Pegylated interferon alpha 2a is an effective and well‐tolerated treatment option for lymphocyte‐variant hypereosinophilic syndrome
Choi, Charles, Moller, Daniel, Tan, Julia, Dou, Carol, Peterson, Erica A., Medvedev, Nadia, Dutz, Jan P, Carruthers, Mollie N., Chen, Luke Y. C.Journal:
British Journal of Haematology
DOI:
10.1111/bjh.16332
Date:
November, 2019
File:
PDF, 83 KB
2019